Microfluidic Open Day 2025 in Paris: glass microfluidic chips and organ‑on‑chip solutions by FEMTOPRINT​

Glass microfluidic devices are at the heart of next‑generation diagnostic, life‑science and organ‑on‑chip systems.​

At the Microfluidics Consortium Open Day 2025 in Paris, FEMTOPRINT will present how high‑precision 3D glass microfabrication enables reliable, scalable microfluidic chips for demanding applications.​​

A must‑attend event for microfluidic technology leaders

The Microfluidics Consortium Open Day 2025 is one of the most important international meetings for companies and researchers developing microfluidic chips, diagnostic platforms and advanced manufacturing solutions.​
CTOs, R&D engineers and product managers attend to explore new technologies for lab‑on‑a‑chip, point‑of‑care diagnostics, organ‑on‑chip and single‑cell analysis.​

FEMTOPRINT’s glass microfluidic chips and manufacturing capabilities

FEMTOPRINT specializes in high‑precision glass microfluidic chip manufacturing, using ultrafast 3D laser micro‑fabrication to create complex channels, mixers and microstructures.​​
This enables robust, chemically resistant microfluidic devices for applications such as liquid biopsy, cell culture, organ‑on‑chip and high‑sensitivity analytical instrumentation.​​

Benefits of glass microfluidics for diagnostics and life sciences

Compared with polymer‑based solutions, glass microfluidic devices provide excellent optical transparency, low autofluorescence and superior chemical compatibility—key advantages for fluorescence detection, imaging and aggressive reagents.​​
FEMTOPRINT’s monolithic glass chips also offer high dimensional stability and biocompatibility, supporting reliable assays over long periods of use.​​

Topics FEMTOPRINT will address in Paris

During the Microfluidics Open Day 2025, FEMTOPRINT will share case studies and practical insights on:​

• Design for manufacturing of custom glass microfluidic chips for diagnostics and life‑science instruments
• Scaling from prototype to small‑ and mid‑volume production using 3D laser micro‑fabrication
• Integration of micro‑optics and micro‑mechanical features into microfluidic platforms (e.g. organ‑on‑chip, cell analysis, imaging)

These sessions are designed for teams seeking industrial‑grade manufacturing partners for complex glass microfluidic devices.​​

Who should attend

The event is particularly relevant for:​

• CTOs and R&D managers developing microfluidic‑based diagnostic or life‑science systems
• Product owners working on organ‑on‑chip, lab‑on‑chip or single‑cell analysis platforms
• Manufacturing, industrialization and sourcing teams searching for reliable glass microfluidic suppliers

Participants will have the opportunity to discuss their specific design and manufacturing challenges directly with FEMTOPRINT’s microfluidics experts.​​

Meet FEMTOPRINT in Paris and book a private presentation

If you are planning new products based on glass microfluidic chips, the Microfluidics Consortium Open Day 2025 in Paris is an ideal opportunity to assess FEMTOPRINT’s capabilities.​
Use the form below to book a private presentation and explore how FEMTOPRINT can support your next microfluidic, diagnostic or organ‑on‑chip project—from feasibility to industrialization.

We will share our expertise and insights on how precision and microfluidic innovation are enabling sophisticated, next-generation solutions across the diagnostics and life sciences sectors. This is a critical talk for understanding the commercial and technological landscape shaped by companies like FEMTOPRINT.

If your work involves microfluidic technologies, whether in R&D, commercialization, or manufacturing, this meeting in Paris 2025 is your essential platform for knowledge exchange and business development.

We look forward to seeing you there to shape the future of microfluidics together.

Discover more, book your private presentation.